Notice2022-00258
National Cancer Institute; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 11, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 7 (Tuesday, January 11, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 7 (Tuesday, January 11, 2022)]
[Notices]
[Page 1426]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-00258]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, Translational and Basic
Research Early Lesions (U54 and U24), March 02, 2022, 09:00 a.m. to
March 03, 2022, 06:00 p.m., National Cancer Institute at Shady Grove,
Room 7W108, 9609 Medical Center Drive, Rockville, Maryland 20850 which
was published in the Federal Register on December 20, 2021, FR Doc
2021-27482, 86 FR 71902.
This notice is being amended to change the meeting date from March
2-3, 2022 to March 15-16, 2022. The meeting times and location will
stay the same. The meeting is closed to the public.
Dated: January 5, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-00258 Filed 1-10-22; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on January 11, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.